Author

Ilise Lombardo

Observed names: I. Lombardo, ILISE LOMBARDO, Ilise D. Lombardo, Lombardo, I.

Institution: Arvelle Therapeutics (Switzerland)

Observed institutions: NewYork–Presbyterian Hospital, Harvard University, Johns Hopkins University, Emory University, Pfizer (United States), Columbia University Irving Medical Center, Mount Desert Island Biological Laboratory, Yale University, Hospital Clínic de Barcelona, Harvard Vanguard Medical Associates, New York State Psychiatric Institute, FORUM Pharmaceuticals (United States), Arvelle Therapeutics (Switzerland), Columbia University

OpenAlex ID: A5044970030

Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia

2002 · Anissa Abi-Dargham, Osama Mawlawi, et al. · Journal of Neuroscience · 724

PDF

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

2015 · Ilise Lombardo, Geetha Ramaswamy, et al. · Alzheimer s & Dementia · 656

Brain Serotonin Transporter Distribution in Subjects With Impulsive Aggressivity: A Positron Emission Study With [ 11 C]McN 5652

2005 · W. Gordon Frankle, Ilise Lombardo, et al. · American Journal of Psychiatry · 261

Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

2016 · Teresa Coelho, Giampaolo Merlini, et al. · Neurology and Therapy · 181

PDF

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

2015 · Richard SE Keefe, Herbert A Meltzer, et al. · Neuropsychopharmacology · 152

PDF

Measurement of Striatal and Extrastriatal Dopamine D 1 Receptor Binding Potential With [ 11 C]NNC 112 in Humans: Validation and Reproducibility

2000 · Anissa Abi-Dargham, Diana Martinez, et al. · Journal of Cerebral Blood Flow & Metabolism · 147

PDF

Tafamidis in Transthyretin Amyloid Cardiomyopathy

2015 · Mathew S. Maurer, Donna R. Grogan, et al. · Circulation Heart Failure · 140

Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients

2010 · Christoph U. Correll, Benjamin G. Druss, et al. · Psychiatric Services · 116

PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756

1999 · Anissa Abi-Dargham, Norman Simpson, et al. · Synapse · 115

Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [11C]McN 5652

2003 · H.Blair Simpson, Ilise Lombardo, et al. · Biological Psychiatry · 94

Two 6-Week, Randomized, Double-Blind, Placebo-Controlled Studies of Ziprasidone in Outpatients With Bipolar I Depression

2012 · Ilise Lombardo, Gary Sachs, et al. · Journal of Clinical Psychopharmacology · 74

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [ 11 C]McN 5652

2002 · Justine Kent, Jeremy Coplan, et al. · Psychopharmacology · 71

Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635

2006 · W. Gordon Frankle, Ilise Lombardo, et al. · Psychopharmacology · 64

Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB

2005 · W. Gordon Frankle, Rajesh Narendran, et al. · Biological Psychiatry · 60

Cloning, characterization, and functional expression of a CNP receptor regulating CFTR in the shark rectal gland

1999 · Stephen G. Aller, Ilise D. Lombardo, et al. · American Journal of Physiology-Cell Physiology · 57

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?

2009 · David B. Allison, Antony D. Loebel, et al. · Psychiatry Research · 51

The Impact of Calories and Fat Content of Meals on Oral Ziprasidone Absorption

2008 · Kuan Gandelman, Jeffrey A. Alderman, et al. · The Journal of Clinical Psychiatry · 51

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia

2015 · Richard S. E. Keefe, George M. Haig, et al. · Schizophrenia Bulletin · 44

PDF

Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies

2009 · S. Stahl, I. Lombardo, et al. · Journal of Affective Disorders · 39

Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection

2009 · Elaine H. Morrato, Brian Cuffel, et al. · Journal of Clinical Psychopharmacology · 38

Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study

2011 · Eduard Vieta, Elizabeth Pappadopulos, et al. · The International Journal of Neuropsychopharmacology · 34

PDF

Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder

2007 · Lewis Warrington, Ilise Lombardo, et al. · CNS Drugs · 26

Reduction of functional disability with atypical antipsychotic treatment: A randomized long term comparison of ziprasidone and haloperidol

2009 · Philip D. Harvey, Elizabeth Pappadopulos, et al. · Schizophrenia Research · 11

Kinetic Derivation of Serotonin 5HT-1A Receptor Binding Potential with [11C]Carbonyl-Way 100635 and Competition Studies with Endogenous Serotonin

1998 · R.V. Parsey, D. Hwang, et al. · NeuroImage · 9

Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone

2010 · W Gordon Frankle, Ilise Lombardo, et al. · Journal of Psychopharmacology · 8

Works count: 54

Citation count: 3,259

H-index: 22

I10-index: 23